Clinical Trials
3 trialsNCT01701674 2025-12-19
Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT04111510 2024-11-21
Autologous Tumor Infiltrating Lymphocytes in Patients With Pretreated Metastatic Triple Negative Breast Cancer
Yale University
Phase 2 Completed
NCT00200577 2017-06-01
TIL
Nantes University Hospital
Phase 3 Completed